Assessment of the Degree of Neurofunctional Disability in Leprosy Patients in a Municipality in Bahia, Brazil
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2024.211539Keywords:
Leprosy, Neuropathy, Degree of physical disability, DeformitiesAbstract
Mycobacterium leprae is an intracellular bacillus with a specific affinity for Schwann cells. The inflammatory process caused by the bacillus leads to demyelination, axonal degeneration, and loss of neural function, resulting in leprosy neuropathy, which manifests as deformities and physical disabilities. This study aimed to evaluate the degree of physical disability and neurological impairment in leprosy cases in an endemic region of Bahia, Brazil. Methods: This retrospective descriptive study utilized secondary data from patients with leprosy treated at a specialized reference center in Paulo Afonso, Bahia, between 2009 and 2020. Data were collected from patient notification records and medical files, tabulated, and analyzed. Results: A total of 194 leprosy cases were analyzed. Among these, 39.7% exhibited some degree of physical disability, and 49.5% were classified as multibacillary. A statistical association was found between physical disability and factors such as low education (illiteracy or incomplete elementary education), male gender, age of 60 years or older, multibacillary cases, dimorphic or virchowian clinical forms, more than five skin lesions, at least one affected nerve, and positive bacilloscopy. The ulnar nerve was the most commonly affected nerve trunk, although physical disabilities were predominantly located in the lower limbs. Conclusion: The high prevalence of physical disabilities and neurological impairment among leprosy patients in this endemic region underscores the need for improved health education, early diagnosis, and strategies to prevent deformities and disabilities. Enhanced understanding of risk factors and preventive measures could help mitigate the impact of leprosy neuropathy on patients’ lives.
Downloads
References
Sugawara-Mikami M, Tanigawa K, Kawashima A, et al. Pathogenicity and virulence of Mycobacterium leprae. Virulence. 2022;13(1):1985-2011. doi:10.1080/21505594.2022.2141987
World Health Organization. Global leprosy (Hansen disease) update, 2021: moving towards interruption of transmission. [Internet]. 2022;97(36):429-450. Available from: https://www.who.int/publications-detail-redirect/who-wer9736-429-450
Ebenezer GJ, Scollard DM. Treatment and Evaluation Advances in Leprosy Neuropathy. Neurotherapeutics. 2021;18(4):2337-2350. doi:10.1007/s13311-021-01153-z
Lau KHV. Neurological Complications of Leprosy. Semin Neurol. 2019;39(4):462-471. doi:10.1055/s-0039-1687884
Khadilkar SV, Patil SB, Shetty VP. Neuropathies of leprosy. J Neurol Sci. 2021;420:117288. doi:10.1016/j.jns.2020.117288
Froes LAR, Sotto MN, Trindade MAB. Leprosy: clinical and immunopathological characteristics. An Bras Dermatol. 2022;97(3):338-347. doi:10.1016/j.abd.2021.08.006
Barroso-Freitas J, Ribas PA da R, Rebello PFB, Navarro-Pennini S. Clinical evolution of neural function in a series of leprosy neuropathy cases after ulnar neurolysis. An Bras Dermatol. 2021;96(4):500-502. doi:10.1016/j.abd.2020.07.015
Pitta IJR, Hacker MA, Vital RT, et al. Leprosy Reactions and Neuropathic Pain in Pure Neural Leprosy in a Reference Center in Rio de Janeiro – Brazil. Front Med. 2022;9:865485. doi:10.3389/fmed.2022.865485
Oliveira P da S, Silva AMF da, Neto LR de S, et al. Avaliação do grau de incapacidade neurofuncional dos pacientes com diagnóstico de Hanseníase/ Assessment ofthedegreeofneurofunctionaldisability in patientsdiagnosedwithleprosy. Brazilian Journal of Health Review. 2021;4(4):15870-15887. doi:10.34119/bjhrv4n4-117
World Health Organization. Towards Zero Leprosy. Global Leprosy (Hansen’s Disease) Strategy 2021–2030. [Internet]. World Health Organization; 2021. Availablefrom: https://apps.who.int/iris/handle/10665/340774
Instituto Brasileiro de Geografia e Estatística. Panorama. [Internet]. Available from: https://cidades.ibge.gov.br/brasil/ba/paulo-afonso/panorama
Lima IF de, Braga IO, Melo IF de SAA de, Nery JS, Takenami IO, Tenório PP. Hanseníase em uma região semiárida da Bahia: uma análise de 2001 a 2017. Revista de Medicina. 2023;102(2):e-201518. doi:10.11606/issn.1679-9836.v102i2e-201518
Silva VS da, Braga IO, Palácio MAV, Takenami I. Cenário epidemiológico da hanseníase e diferenças por sexo. Revista da Sociedade Brasileira de Clínica Médica. 2021;19(2):74-81.
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Portaria SCTIE/MS nº 67, de 7 de Julho de 2022. [Internet]. Available from: https://www.in.gov.br/web/dou
Bandeira SS, Pires CA, Quaresma JAS. Nerve Damage in Young Patients with Leprosy Diagnosed in an Endemic Area of the Brazilian Amazon: A Cross-Sectional Study. J Pediatr. 2017;185:143-148. doi:10.1016/j.jpeds.2017.02.035
Sanchez MN, Nery JS, Pescarini JM, et al. Physical disabilities caused by leprosy in 100 million cohort in Brazil. BMC Infect Dis. 2021;21(1):290. doi:10.1186/s12879-021-05846-w
Dharmawan Y, Fuady A, Korfage I, Richardus JH. Individual and community factors determining delayed leprosy case detection: A systematic review. PLoSNegl Trop Dis. 2021;15(8):e0009651. doi:10.1371/journal.pntd.0009651
Srinivas G, Muthuvel T, Lal V, Vaikundanathan K, Schwienhorst-Stich EM, Kasang C. Risk of disability among adult leprosy cases and determinants of delay in diagnosis in five states of India: A case-control study. PLoSNeglTropDis. 2019;13(6):e0007495. doi:10.1371/journal.pntd.0007495
Costa RMPG, Fernandes MA, Santos GPG, Rocha D de M, Santos AMR dos, Avelino FVSD. Social stigma and mental health impairment in people with leprosy: An integrative review. Leprosy Review. 2022;93(3):254-264. doi:10.47276/lr.93.3.254
Pitta IJR, Hacker M de AVB, Andrade LR, et al. Follow-up assessment of patients with Pure Neural Leprosy in a reference center in Rio de Janeiro-Brazil. PLoSNegl Trop Dis. 2022;16(1):e0010070. doi:10.1371/journal.pntd.0010070
Rathod SP, Jagati A, Chowdhary P. Disabilities in leprosy: an open, retrospective analyses of institutional records. An Bras Dermatol. 2020;95(1):52-56. doi:10.1016/j.abd.2019.07.001
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Humberto Baptista Costa, Isaque Oliveira Braga, Vitoria Santos da Silva, Maria Augusta Vasconcelos Palácio, Maria Luisa de Carvalho Correia, Iukary Oliveira Takenami
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Funding data
-
Fundação de Amparo à Pesquisa do Estado da Bahia
Grant numbers SUS0017/2021